SKI Market

A+| A| A-|

Indian Indices

Sensex

78,180.72 -104.35
( -0.13%)

Global Indices

Nasdaq

53,071.47 150.40
(0.28%)

Dow Jones

7,557.54 53.30
(0.71%)

Hang Seng

68,399.59 -1,338.10
(-1.92%)

Nikkei 225

10,685.41 33.64
(0.32%)

Forex

USD-INR

95.19 -0.09
(-0.09%)

EUR-INR

108.86 0.10
(0.10%)

GBP-INR

127.02 0.03
(0.03%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

655.3150344

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

30.83

40620.5

EPS(TTM)

Face Value()

Div & Yield %

79.87

0.81

Back

HLE Glascoat consolidated net profit declines 66.67% in the December 2025 quarter

Feb 11,2026

Net profit of HLE Glascoat declined 66.67% to Rs 2.83 crore in the quarter ended December 2025 as against Rs 8.49 crore during the previous quarter ended December 2024. Sales rose 41.35% to Rs 326.57 crore in the quarter ended December 2025 as against Rs 231.03 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	326.57	231.03	41
OPM %	6.46	11.10	-
PBDT	16.73	18.79	-11
PBT	6.83	11.41	-40
NP	2.83	8.49	-67

78,180.72 -104.35 ( -0.13%)

53,071.47 150.40 (0.28%)

7,557.54 53.30 (0.71%)

68,399.59 -1,338.10 (-1.92%)

10,685.41 33.64 (0.32%)

95.19 -0.09 (-0.09%)

108.86 0.10 (0.10%)

127.02 0.03 (0.03%)

0.59 0.00 (-0.02%)